Abstract
Platinum(IV) prodrug overcomes acquired resistance to cisplatin in prostate cancer by inhibiting fatty acid oxidation.
Original language | English (US) |
---|---|
Pages (from-to) | 1257-1259 |
Number of pages | 3 |
Journal | ACS Central Science |
Volume | 9 |
Issue number | 7 |
DOIs | |
State | Published - Jul 26 2023 |
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering